期刊文献+

Effects of Surface Modification of Upconversion Nanoparticles on Cellular Uptake and Cytotoxicity 被引量:1

Effects of Surface Modification of Upconversion Nanoparticles on Cellular Uptake and Cytotoxicity
原文传递
导出
摘要 Lanthanide-doped upconversion nanoparticles(UCNPs) are great promising to apply to biomedical imaging and therapy. We prepared NaYF4:yb3+,Er3+ nanoparticles with different surface ligands, i.e., without any ligands(bare), coordinated with 2-aminoethyl dihydrogen phosphate(AEP), polyacrylic acid(PAA) or polyallylamine (PAAm), via a simple two-step ligand exchange of oleic acid capped NaYF4:Yba+,Er3+ nanoparticles. Although the surface modification retained the crystal structure and transimission electron microscope(TEM) size distribution of the nanoparticles, and good dispersibility in aqueous solution and did not significantly change the upconversion luminescence, distinct differences were observed in the surface charge and hydrodynamic diameter. The cellular uptake and cytotoxicity of the nanoparticles were studied on two different cell lines, breast cancer MCF-7 and fibroblast 3T3. Confocal microscopy images demonstrate that PAAm-coordinated UCNPs can enhance the cellular uptake and endocytosis, whereas AEP- and PAA-coordinated UCNPs show a very low level of nonspecific adsorption Biocompatibility studies based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay, however, indicate that PAAm-coordinated UCNPs are more toxic than the other two, and thus need further modifiaction(like PEG coordinating) to improve their biocompatibility. These results are important to the knowledge base required for the biomedical application of the UCNPs. Lanthanide-doped upconversion nanoparticles(UCNPs) are great promising to apply to biomedical imaging and therapy. We prepared NaYF4:yb3+,Er3+ nanoparticles with different surface ligands, i.e., without any ligands(bare), coordinated with 2-aminoethyl dihydrogen phosphate(AEP), polyacrylic acid(PAA) or polyallylamine (PAAm), via a simple two-step ligand exchange of oleic acid capped NaYF4:Yba+,Er3+ nanoparticles. Although the surface modification retained the crystal structure and transimission electron microscope(TEM) size distribution of the nanoparticles, and good dispersibility in aqueous solution and did not significantly change the upconversion luminescence, distinct differences were observed in the surface charge and hydrodynamic diameter. The cellular uptake and cytotoxicity of the nanoparticles were studied on two different cell lines, breast cancer MCF-7 and fibroblast 3T3. Confocal microscopy images demonstrate that PAAm-coordinated UCNPs can enhance the cellular uptake and endocytosis, whereas AEP- and PAA-coordinated UCNPs show a very low level of nonspecific adsorption Biocompatibility studies based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay, however, indicate that PAAm-coordinated UCNPs are more toxic than the other two, and thus need further modifiaction(like PEG coordinating) to improve their biocompatibility. These results are important to the knowledge base required for the biomedical application of the UCNPs.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2016年第3期474-479,共6页 高等学校化学研究(英文版)
关键词 UPCONVERSION CYTOTOXICITY Surface modification Upconversion Cytotoxicity Surface modification
  • 相关文献

参考文献20

  • 1Medintz I., Uyeda H., Goldman E., Mattoussi H., Nat. Mater., 2005, 4(6), 435.
  • 2Lu A. H., Salabas E. L., Schttth F., Angew. Chem. Int. Ed., 2007, 46(8), 1222.
  • 3Lee J. H., Huh Y. M? Jun Y. W., Seo J. W., Jang J. T., Song H. T.,Kim S., Cho E. J., Yoon H. G? Suh J. S., Nat. Med., 2006, 73(1), 95.
  • 4Cho K? Wang X., Nie S., Shin D. M? Clin. Cancer Res., 2008, 14(A), 1310.
  • 5Shi J., Votruba A. R., Farokhzad O. C., Langer R., Nano Lett., 2010, 10(9), 3223.
  • 6Cheng L., Yang K., Li Y., Chen J., Wang C., Shao M., Lee S. T., Liu Z., Angew. Chem. Int. Ed, 2011, 50(33), 7523.
  • 7Park Y. 1., Kim J. H., Lee K. T., Jeon K. S., Na H. B., Yu J. H., KimH. M., Lee N., Choi S. H., Baik S. I., Adv. Mater., 2009, 27(44), 4467.
  • 8Qian H. S., Guo H. C., Ho P. C. L., Mahendran R., Zhang Y., Small, 2009, 5(20), 2285.
  • 9Wang C., Tao H., Cheng L., Liu Z., Biomaterials 2011, 32(26), 6145.
  • 10Jiang S., Zhang Y., Lim K. M., Sim E. K., Ye L., Nanotechnology,2009, 20(15), 155101.

同被引文献7

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部